Saturday 17 October 2026
Export TEM’s income statement to Excel — free account
Tempus AI, Inc.
TEM Healthcare Health Information Services
Tempus AI, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 83.4% from fiscal 2024. In the quarter to June 2026, revenue grew 21.6%, EPS grew 112.0%, free cash flow fell 153.7% and total debt rose 70.5%, each against the same quarter a year earlier. Dividend growth for three consecutive years, revenue growth for three.
64.72
6.41
−9.01%
Follow TEM
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
7.28 | 5.93 | 8.09 | 12.78 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(1,385.06) | (110.39) | (279.72) | (117.82) | |
P/B ratio |
23.43 | 19.43 | 20.94 | 27.80 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
7.66 | 6.37 | 8.47 | 13.21 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(46.19) | (46.75) | (49.41) | (66.22) | |
EV/FCF |
(40.18) | (39.52) | (43.92) | (58.55) | |
Quick Ratio |
3.01 | 2.98 | 2.86 | 2.98 | |
Current Ratio |
3.30 | 3.31 | 3.13 | 3.28 | |
Net Debt/EBITDA |
(11.31) | (10.42) | (14.71) | (14.98) | |
Debt/Assets |
57.51% | 57.76% | 54.49% | 54.60% | |
Debt/Equity |
3.06 | 2.96 | 2.52 | 2.45 | |
Asset Turnover |
0.72 | 0.74 | 0.79 | 0.68 | |
Operating CF/Net income |
(1.33) | 0.58 | 0.68 | 1.50 | |
Capex/Depreciation |
(0.40) | (0.36) | (0.22) | (0.28) | |
Interest Coverage |
(7.38) | (5.91) | (4.02) | (3.96) | |
Research and Development Expense of Revenue |
25.25% | 27.05% | 24.68% | 24.85% | |
Selling, General and Administrative Expense of Revenue |
59.05% | 61.07% | 56.78% | 56.22% | |
Intangible Assets out of Total Assets |
0.33 | 0.38 | 0.36 | 0.37 | |
Share Based Compensation of Revenue |
14.15% | 15.14% | 12.35% | 10.17% | |
Graham Net Nets |
(0.06) | (0.08) | (0.06) | (0.04) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(2.47%) | (3.78%) | (2.39%) | (1.47%) | |
Free Cash Flow Yield |
(2.62%) | (2.72%) | (2.38%) | (1.77%) | |
Revenue per Share |
2.13 | 1.95 | 2.11 | 1.91 | |
Operating CF per Share |
(0.04) | (0.41) | (0.21) | (0.68) | |
Capex per Share |
(0.06) | (0.06) | (0.04) | (0.05) | |
Free Cash Flow per Share |
(0.10) | (0.47) | (0.25) | (0.73) | |
Cash per Share |
4.54 | 3.57 | 4.33 | 4.34 | |
Shareholders Equity per Share |
2.47 | 2.33 | 2.82 | 2.90 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.47 | 2.33 | 2.82 | 2.90 | |
Free Cash Flow |
(18.62) | (83.34) | (43.12) | (127.89) | |
Working Capital |
899.37 | 735.99 | 794.79 | 796.48 | |
Capital Expenditures |
(11.09) | (10.07) | (6.34) | (8.05) | |
Net Current Asset Value |
(630.11) | (664.74) | (616.34) | (627.09) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.03 | 0.03 | 0.02 | 0.02 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
313.60 | 285.61 | 232.99 | 214.62 | |
Average Payables |
76.57 | 64.88 | 67.90 | 54.29 | |
Average Inventory |
50.56 | 51.16 | 45.06 | 45.56 | |
Average Assets |
1,995.64 | 1,839.11 | 1,600.48 | 1,626.58 | |
Average Common Equity |
377.25 | 371.30 | 273.83 | 280.78 |
Columns are period end dates